
Oral Corticosteroid Improves Walking Ability in Patients with Refractory Lumbar Spinal Stenosis
How to Cite
OrthoEvidence. Oral Corticosteroid Improves Walking Ability in Patients with Refractory Lumbar Spinal Stenosis. ACE Report. 2021;10(1):16. Available from: https://myorthoevidene.com/AceReport/Report/12935
A short-term oral corticosteroid for refractory lumbar spinal stenosis: a double-blinded randomized placebo-controlled clinical trial
Int J Rehabil Res. 2020 Dec;43(4):342-346.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Ninety-three patients with refractory lumbar spinal stenosis (LSS) were randomized to receive 1 week of oral corticosteroid (prednisolone; n=47) or a placebo (n=46) for the improvement of functionality and relief of pain. The primary outcomes of interest was the improvement in walking distance and Oswestry Disability Index (ODI). The secondary outcomes of interest was pain score on a Numeric Ratin...
To view the full report, start your 30-day free trial today
No credit card required
JOIN LOGIN Forgot Password?Not sure if you want to join OrthoEvidence?
Access this report without an Account.Success, an email containing a link to access this report has been sent to your inbox.
Explore some of our unlocked reports below!

Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MORE
Please Login or Join to leave comments.